Clinical Trial Update: Perioperative Cancer Cell Dissemination and Systemic Immune Suppression in Resectable Ductal Pancreatic Adenocarcinoma

View source ↗

Summary

A completed clinical trial evaluating perioperative cancer cell dissemination and systemic immune suppression in patients with resectable pancreatic ductal aden…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Snippet

Sponsor: KU Leuven | Conditions: Pancreatic Neoplasms, Adenocarcinoma | Status: COMPLETED